DENALI ADVISORS LLC – Revance Therapeutics, Inc. Transaction History
DENALI ADVISORS LLC portfolio value:
$122,000
portfolio value
DENALI ADVISORS LLC quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -18.18% | -1K shares | 46K | $27 | 4.5K |
| Q2 2022 | share | Decrease | -15.38% | -1K shares | -51K | $13.82 | 5.5K |
| Q1 2022 | share | 0.00% | 0 shares | 21K | $19.5 | 6.5K | |
| Q4 2021 | share | Increase | 0.00% | 6.5K shares | 106K | $16.49 | 6.5K |